HaranathParepallyMD

PubMed

• 8 citations
  Clozapine and risperidone in moderately refractory schizophrenia: a 6-month randomized double-blind comparison.
  Nina R. Schooler, Stephen R. Marder, K. N. R. Chengappa, Georgios Petrides, Donna Ames, William C. Wirshing, Marjorie McMeniman, Robert W. Baker, Haranath Parepally, D...> ;The Journal of Clinical Psychiatry. 2016 May 25
• 8 citations
  The impact of olanzapine on tardive dyskinetic symptoms in a state hospital population.
  Jaspreet S. Brar, Haranath Parepally, Lokaranjit Chalasani, A. Gopalani, Nicole Appel, K. N. Roy Chengappa> ;Annals of Clinical Psychiatry. 2008 Jul 1
• 26 citations
  A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type.
  K. N. Roy Chengappa, David J. Kupfer, Haranath Parepally, Vineeth John, Ranita Basu, Joan Buttenfield, Patricia J. Schlicht, Patricia R. Houck, Jaspreet S. Brar, Samue...> ;Bipolar Disorders. 2007 Sep 1
• 17 citations
  Leukopenia in clozapine treated patients may be induced by other drugs: a case series.
  Mary Jo Imbarlina, Sonali Sarkar, Shashi Marwah, Haranath Parepally, Phillip R. Johnston, Jaspreet S. Brar, K. N. Roy Chengappa> ;European Psychiatry. 2004 Dec 1
• 320 citations
  Cognitive Enhancement Therapy for Schizophrenia: Effects of a 2-Year Randomized Trial on Cognition and Behavior
  Gerard E. Hogarty, Samuel Flesher, Richard F. Ulrich, Mary Carter, Deborah P. Greenwald, Michael F. Pogue-Geile, Matcheri Kechavan, Susan Cooley, Ann Louise DiBarry, A...> ;Archives of General Psychiatry. 2004 Sep 1
• 101 citations
  The prevalence of the metabolic syndrome in patients with schizoaffective disorder--bipolar subtype.
  Ranita Basu, Jaspreet S. Brar, K. N. Roy Chengappa, Vineeth John, Haranath Parepally, Samuel Gershon, Patricia J. Schlicht, David J. Kupfer> ;Bipolar Disorders. 2004 Aug 1
• 1 citations
  Attitudes towards taking Medicine among those patients who either received Olanzapine or First Generation Antipsychotic Agents.
  N R Chengappa, Haranath Parepally, Jaspreet S. Brar, A. Gopalani, Lokaranjit Chalasani, Jonathan Bear, Joseph Levine> ;Indian Journal of Psychiatry. 2003 Jul 1
• 18 citations
  A random-assignment, double-blind, clinical trial of once- vs twice-daily administration of quetiapine fumarate in patients with schizophrenia or schizoaffective disor...
  K. N. Roy Chengappa, Haranath Parepally, Jaspreet S. Brar, Jamie Mullen, Ann Shilling, Jeffrey M. Goldstein> ;Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 2003 Apr 1
• 90 citations
  Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review.
  K. N. Roy Chengappa, Lokaranjit Chalasani, Jaspreet S. Brar, Haranath Parepally, Patricia R. Houck, Joseph Levine> ;Clinical Therapeutics. 2002 Oct 1
• 14 citations
  The use of concomitant medications in psychiatric inpatients treated with either olanzapine or other antipsychotic agents: A naturalistic study at a state psychiatric ...
  Haranath Parepally, Sudeep Chakravorty, Joseph Levine, Jaspreet S. Brar, Amit M Patel, J. Baird, Lokaranjit Chalasani, Joyce A Delaney, R Atzert, K. N. Roy Chengappa> ;Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2002 Apr 1
• 13 citations
  Obesity and medical illnesses in psychiatric patients admitted to a long-term psychiatric facility.
  Joseph Levine, K. N. Roy Chengappa, Amit M Patel, Anthony H. Vagnucci, Vineeth John, Jaspreet S. Brar, Lokaranjit Chalasani, Haranath Parepally, Rohan Ganguli> ;Journal of Psychiatric Practice. 2001 Nov 1
• 60 citations
  Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: a case-series
  K. N. Roy Chengappa, Joseph Levine, D. Rathore, Haranath Parepally, R Atzert> ;European Psychiatry. 2001 Apr 1
• 24 citations
  Impact of risperidone on seclusion and restraint at a state psychiatric hospital.
  K. N. R. Chengappa, Joseph Levine, Richard F. Ulrich, Haranath Parepally, Jaspreet S. Brar, R Atzert, R Brienzo, A. Gopalani> ;Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 2000 Nov 1
• 6 citations
  Side effect profile of enteric-coated divalproex sodium versus valproic acid.
  Joseph Levine, K. N. R. Chengappa, Haranath Parepally> ;The Journal of Clinical Psychiatry. 2000 Sep 30
• 51 citations
  Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine.
  Kn Roy Chengappa, Bruce G. Pollock, Haranath Parepally, Joseph Levine, Margaret A. Kirshner, Jaspreet S. Brar, Rebecca Zoretich> ;Journal of Clinical Psychopharmacology. 2000 Jun 1
• 127 citations
  Topiramate as add-on treatment for patients with bipolar mania
  Kn Roy Chengappa, Dilip Rathore, Joseph Levine, R Atzert, Lalith Solai, Haranath Parepally, Harry Levin, Nicolas Moffa, Joyce A Delaney, Jaspreet S. Brar> ;Bipolar Disorders. 1999 Sep 1
• 86 citations
  Clozapine Reduces Severe Self-Mutilation and Aggression in Psychotic Patients With Borderline Personality Disorder
  K. N. R. Chengappa, T. Ebeling, J. S. Kang, Joseph Levine, Haranath Parepally> ;The Journal of Clinical Psychiatry. 1999 Jul 1
• 15 citations
  Risperidone Use at a State Hospital: A Clinical Audit 2 Years After the First Wave of Risperidone Prescriptions
  K. N. R. Chengappa, S. Sheth, Jaspreet S. Brar, Haranath Parepally, Stevan Marcus, A. Gopalani, A. Palmer, Robert W. Baker, Nina Schooler> ;The Journal of Clinical Psychiatry. 1999 Jun 30
• 77 citations
  Clozapine Withdrawal-Emergent Dystonias and Dyskinesias: A Case Series
  Ahmed S, K. N. R. Chengappa, Naidu Vr, Robert W. Baker, Haranath Parepally, Nina Schooler> ;The Journal of Clinical Psychiatry. 1998 Sep 15
• 26 citations
  The Effects of Clozapine on Negative Symptoms in Patients with Schizophrenia with Minimal Positive Symptoms
  Jaspreet S. Brar, K. N. Roy Chengappa, Haranath Parepally, Alan R. Sandman, Suzanne B. Kreinbrook, Sapna A. Sheth, Rohan Ganguli> ;Annals of Clinical Psychiatry. 1997 Dec 1
• Olanzapine use in subjects with pervasive developmental disorder displaying aggression and/or self-mutilation.
  Chengappa, K. N., Rumble, C. T., Nasr, F., Parepally, H.> ;J Psychiatr Pract. 2001 May
• Join now to see all